Cargando…

Differential Expression of PD-L1 during Cell Cycle Progression of Head and Neck Squamous Cell Carcinoma

The expression of PD-L1 by tumor cells is mainly associated with its immunosuppressive effect. In fact, PD-1/PD-L1 immune checkpoint inhibitors demonstrated remarkable effects in advanced cancer patients including HNSCC. In this context, irradiation is currently being investigated as a synergistic t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schulz, Daniela, Wetzel, Martin, Eichberger, Jonas, Piendl, Gerhard, Brockhoff, Gero, Wege, Anja K., Reichert, Torsten E., Ettl, Tobias, Bauer, Richard J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8658507/ https://www.ncbi.nlm.nih.gov/pubmed/34884892 http://dx.doi.org/10.3390/ijms222313087

Ejemplares similares

PD-L1 Influences Cell Spreading, Migration and Invasion in Head and Neck Cancer Cells
por: Eichberger, Jonas, et al.
Publicado: (2020)

The Aurora-Kinase A Phe31-Ile polymorphism as possible predictor of response to treatment in head and neck squamous cell carcinoma
por: Baumann, Alexander, et al.
Publicado: (2018)

Increased PD-L1 expression in radioresistant HNSCC cell lines after irradiation affects cell proliferation due to inactivation of GSK-3beta
por: Schulz, Daniela, et al.
Publicado: (2019)

BMSC–HNC Interaction: Exploring Effects on Bone Integrity and Head and Neck Cancer Progression
por: Eichberger, Jonas, et al.
Publicado: (2023)

A novel rabbit derived anti-HER2 antibody with pronounced therapeutic effectiveness on HER2-positive breast cancer cells in vitro and in humanized tumor mice (HTM)
por: Wege, Anja Kathrin, et al.
Publicado: (2020)

Protein kinase C targeting of luminal (T-47D), luminal/HER2-positive (BT474), and triple negative (HCC1806) breast cancer cells in-vitro with AEB071 (Sotrastaurin) is efficient but mediated by subtype specific molecular effects
por: Albert, Veruschka, et al.
Publicado: (2022)

Loss of MMP-27 Predicts Mandibular Bone Invasion in Oral Squamous Cell Carcinoma
por: Eichberger, Jonas, et al.
Publicado: (2022)

Regulation of Programmed Death Ligand 1 (PD-L1) Expression in Breast Cancer Cell Lines In Vitro and in Immunodeficient and Humanized Tumor Mice
por: Rom-Jurek, Eva-Maria, et al.
Publicado: (2018)

The response of head and neck squamous cell carcinoma to cetuximab treatment depends on Aurora kinase A polymorphism
por: Pickhard, Anja, et al.
Publicado: (2014)

Immune Checkpoint Profiling in Humanized Breast Cancer Mice Revealed Cell-Specific LAG-3/PD-1/TIM-3 Co-Expression and Elevated PD-1/TIM-3 Secretion
por: Bruss, Christina, et al.
Publicado: (2023)

Postoperative Delirium after Reconstructive Surgery in the Head and Neck Region
por: Taxis, Juergen, et al.
Publicado: (2022)

The presence of PD-1 positive tumor infiltrating lymphocytes in triple negative breast cancers is associated with a favorable outcome of disease
por: Brockhoff, Gero, et al.
Publicado: (2017)

Opposing MMP-9 Expression in Mesenchymal Stromal Cells and Head and Neck Tumor Cells after Direct 2D and 3D Co-Culture
por: Waltera, Anna, et al.
Publicado: (2023)

IL-15 enhances the anti-tumor activity of trastuzumab against breast cancer cells but causes fatal side effects in humanized tumor mice (HTM)
por: Wege, Anja K, et al.
Publicado: (2016)

TIGIT Expression on Intratumoral Lymphocytes Correlates with Improved Prognosis in Oral Squamous Cell Carcinoma
por: Eichberger, Jonas, et al.
Publicado: (2022)

Advanced Immune Cell Profiling by Multiparameter Flow Cytometry in Humanized Patient-Derived Tumor Mice
por: Bruss, Christina, et al.
Publicado: (2022)

TGFβ(+) small extracellular vesicles from head and neck squamous cell carcinoma cells reprogram macrophages towards a pro‐angiogenic phenotype
por: Ludwig, Nils, et al.
Publicado: (2022)

Checkpoint Inhibitors in Cancer Therapy: Clinical Benefits for Head and Neck Cancers
por: Ettl, Tobias, et al.
Publicado: (2022)

CX3CL1 Overexpression Prevents the Formation of Lung Metastases in Trastuzumab-Treated MDA-MB-453-Based Humanized Tumor Mice (HTM)
por: Wege, Anja Kathrin, et al.
Publicado: (2021)

OSCC in Never-Smokers and Never-Drinkers Is Associated with Increased Expression of Tumor-Infiltrating Lymphocytes and Better Survival
por: Fiedler, Mathias, et al.
Publicado: (2023)

Intratumor heterogeneity of PD-L1 expression in head and neck squamous cell carcinoma
por: Rasmussen, Jacob H., et al.
Publicado: (2019)

Staging more important than grading? Evaluation of malignancy grading, depth of invasion, and resection margins in oral squamous cell carcinoma
por: Wunschel, Michael, et al.
Publicado: (2020)

Purine Metabolites in Tumor-Derived Exosomes May Facilitate Immune Escape of Head and Neck Squamous Cell Carcinoma
por: Ludwig, Nils, et al.
Publicado: (2020)

Influence of early elective tracheostomy on the incidence of postoperative complications in patients undergoing head and neck surgery
por: Meier, Johannes, et al.
Publicado: (2019)

Small Extracellular Vesicles from Head and Neck Squamous Cell Carcinoma Cells Carry a Proteomic Signature for Tumor Hypoxia
por: Głuszko, Alicja, et al.
Publicado: (2021)

HER4 expression in estrogen receptor-positive breast cancer is associated with decreased sensitivity to tamoxifen treatment and reduced overall survival of postmenopausal women
por: Wege, Anja Kathrin, et al.
Publicado: (2018)

Ferroportin depletes iron needed for cell cycle progression in head and neck squamous cell carcinoma
por: Belvin, Benjamin Ross, et al.
Publicado: (2023)

PD-L1: a novel prognostic biomarker in head and neck squamous cell carcinoma
por: Müller, Tim, et al.
Publicado: (2017)

Oxygen Deprivation Modulates EGFR and PD-L1 in Squamous Cell Carcinomas of the Head and Neck
por: Zahnreich, Sebastian, et al.
Publicado: (2021)

Tumor hypoxia is associated with resistance to PD-1 blockade in squamous cell carcinoma of the head and neck
por: Zandberg, Dan P, et al.
Publicado: (2021)

Performance of Different Diagnostic PD-L1 Clones in Head and Neck Squamous Cell Carcinoma
por: Ribbat-Idel, Julika, et al.
Publicado: (2021)

A decade of reconstructive surgery: outcome and perspectives of free tissue transfer in the head and neck. Experience of a single center institution
por: Spoerl, Steffen, et al.
Publicado: (2020)

HBD3 Induces PD-L1 Expression on Head and Neck Squamous Cell Carcinoma Cell Lines
por: Gomez Hernandez, Maria Paula, et al.
Publicado: (2019)

Spatial Profiles of Intratumoral PD-1(+) Helper T Cells Predict Prognosis in Head and Neck Squamous Cell Carcinoma
por: Yoshimura, Kanako, et al.
Publicado: (2021)

Prognostic Value of Perineural Invasion on Survival and Recurrence in Oral Squamous Cell Carcinoma
por: Spoerl, Steffen, et al.
Publicado: (2022)

PKM2 Modulation in Head and Neck Squamous Cell Carcinoma
por: Boschert, Verena, et al.
Publicado: (2022)

PD-L1 expression is associated with epithelial-mesenchymal transition in head and neck squamous cell carcinoma
por: Ock, Chan-Young, et al.
Publicado: (2016)

PD-L1 and MRN synergy in platinum-based chemoresistance of head and neck squamous cell carcinoma
por: Shen, Bin, et al.
Publicado: (2019)

PD-L1 expression in the microenvironment and the response to checkpoint inhibitors in head and neck squamous cell carcinoma
por: Evrard, D., et al.
Publicado: (2020)

Automated PD-L1 Scoring Using Artificial Intelligence in Head and Neck Squamous Cell Carcinoma
por: Puladi, Behrus, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0a9t18vu64sfg81d734c0213qp